REFERENCES
- Swendsen J D, Merikangas K R. The comorbidity of depression and substance use disorders. Clinical Psychology Review 2000; 20(2)173–189
- Kendler K S. The diagnostic validity of melancholic major depression in a population-based sample of female twins. Archives of General Psychiatry 1997; 54(4)299–304
- Leventhal A M, Francione C, Zimmerman M. Associations between depression subtypes and substance use disorders. Psychiatry Research, (in press)
- Melartin T, Leskelä U, Rytsälä H, Sokero P. Lestelä-Mielonen P, Isometsä Co-morbidity E. and stability of melancholic features in DSM-IV major depressive disorder. Psychological Medicine 2004; 34: 1443–1452
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. American Psychiatric Association, Washington, DC 1994
- Pizzagalli D A, Oakes T R, Fox A S, Chung M K, Larson C L, Abercrombie H C, Schaefer S M, Benca R M, Davidson R J. Functional but not structural subgenual prefrontal cortex abnormalities in melancholia. Molecular Psychiatry 2004; 9(4)393–325
- Gold P W, Chrousos G P. Organization of the stress system and its dysregulation in melancholic and atypical depression: High vs. low CRH/NE states. Molecular Psychiatry 2002; 7(3)254–275
- Grant B F. Comorbidity between DSM-IV drug use disorders and major depression: Results of a national survey of adults. Journal of Substance Abuse 1995; 7(4)481–497
- Lewinsohn P M, Petit J W, Joiner T EJ, Seeley J R. The symptomatic expression of major depressive disorder in adolescents and young adults. Journal of Abnormal Psychology 2003; 112(2)244–252
- Miles H, Johnson S, Amponsah-Afuwape S, Leese M, Finch E, Thornicroft G. Characteristics of subgroups of individuals with psychotic illness and a comorbid substance use disorder. Psychiatric Services 2003; 54(4)554–561
- Orvaschel H, Puig-Antich J, Chambers W J, Tabrizi M A, Johnson R. Retrospective assessment of prepubertal major depression with the Kiddie-SADS-E?. Journal of the American Academy of Child and Adolescent Psychiatry 1982; 21: 392–397
- Keller M B, Lavori P W, Friedman B, Nielsen E. The longitudinal interval follow-up evaluation: A comprehensive method for assessing outcome in prospective longitudinal studies. Archives of General Psychiatry 1987; 44(6)540–548
- Hamilton M. A rating scale for depression?. Journal of Neurology, Neurosurgery and Psychiatry 1960; 23: 56–61
- Lewinsohn P M, Rohde P, Brown R A. Level of current and past adolescent cigarette smoking as predictors of future substance use disorders in young adulthood. Addiction 1999; 94(6)913–921
- Tremblay L K, Naranjo C A, Cardenas L, Herrmann N, Busto U E. Probing brain reward system function in major depressive disorder: altered response to dextroamphetamine. Archives of General Psychiatry 2002; 59(5)409–416
- Tremblay L K, Naranjo C A, Graham S J, Herrmann N, Mayberg H S, Hevenor S, Busto U E. Functional Neuroanatomical Substrates of Altered Reward Processing in Major Depressive Disorder Revealed by a Dopaminergic Probe. Archives of General Psychiatry 2005; 62(11)1228–1236